Company name Ekso Bionics Holdings, Inc.
Stock symbol EKSO
Class period January 4, 2016 – August 7, 2017
Lead plaintiff deadline March 5, 2018
Court Eastern District of New York
Status Under Investigation

NEW YORK, January 3, 2018 – Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) securities between March 15, 2017 and December 27, 2017 (the “Class Period”).  Investors have until March 5, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

On December 14, 2017, Ekso announced that “the Company’s internal control over financial reporting as of December 31, 2016 should no longer be relied upon and that a material weakness in the Company’s internal control over financial reporting existed as of such date.”  Following this news, Ekso’s share price fell $0.15, or 6.17%, to close at $2.28 on December 15, 2017.

On December 27, 2017, post-market, Ekso filed its amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017.  The following trading day, shares of Ekso fell $0.34, or 13.2%, to close at $2.23 per share on December 28, 2017.

The complaint alleges that, throughout the class period, defendants made false and/or misleading statements and/or failed to disclose that: (1) there was a material weakness in Ekso’s internal control over financial reporting and Ekso’s disclosure controls and procedures were not effective; and (2) as a result, Defendants public statements were materially false and misleading at all relevant times.

If you purchased or otherwise acquired Ekso securities and suffered a loss, continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

Join the action by filling out the form below

First name*

Last name*

City, state ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?
YesNo


Call to provide more information: Tel: (212) 308-4648

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.